There are over 10,000 human genetic diseases, and mutations in at least 4,000 genes may directly cause or strongly correlate to a disease. Oncogenesis also strongly correlates with mutations on tumor suppressor genes. 10-15% of such mutations are estimated to be premature termination codons (PTC), causing protein translation to stop early. The resulting truncated proteins often are not stable or functional, leading to diseases. Because there are only 3 types of termination codons, if a therapy can treat the effect of one type of termination codons, it may be developed to treat all diseases caused by this termination codon, regardless of mutation location or specific gene or disease.